Multiple Sclerosis Subtypes Symptoms Diagnosis and Treatment News


Diagram of Multiple Sclerosis SymptomsMultiple sclerosis (MS) formerly known as disseminated sclerosis or encephalomyelitis disseminata), is a chronic, potentially debilitating disease that affects your brain and spinal cord (central nervous system).

An estimated 400,000 Americans have MS. It generally first occurs in people between the ages of 20 and 50. The disease is twice as common in women as in men.

The illness is probably an autoimmune disease, which means your immune system responds as if part of your body is a foreign substance.

The name multiple sclerosis refers to the scars (scleroses - better known as plaques or lesions) in the white matter. Multiple sclerosis may take several forms, with new symptoms occurring either in discrete attacks (relapsing forms) or slowly accumulating over time (progressive forms).

MS can cause a variety of symptoms, including changes in sensation (hypoesthesia), muscle weakness, abnormal muscle spasms, or difficulty in moving; difficulties with coordination and balance (ataxia); problems in speech (dysarthria) or swallowing (dysphagia), visual problems (nystagmus, optic neuritis, or diplopia), fatigue and acute or chronic pain syndromes, bladder and bowel difficulties, cognitive impairment, or emotional symptomatology (mainly depression).

MS affects the neurons in the areas of the brain and spinal cord known as the white matter. These cells carry signals in between the grey matter areas, where the processing is done, and between these and the rest of the body.

In MS, your body directs antibodies and white blood cells against proteins in the myelin sheath surrounding nerves in your brain and spinal cord. This causes inflammation and injury to the sheath and ultimately to your nerves. The result may be multiple areas of scarring (sclerosis). The damage slows or blocks muscle coordination, visual sensation and other nerve signals.

Multiple sclerosis relapses are often unpredictable and can occur without warning with no obvious inciting factors. Some attacks, however, are preceded by common triggers. In general, relapses occur more frequently during spring and summer than during autumn and winter. Infections, such as the common cold, influenza, and gastroenteritis, increase the risk for a relapse.

The disease varies in severity, ranging from a mild illness to one that results in permanent disability.

Despite the ongoing efforts of medical scientists to reveal the factors responsible for causing multiple sclerosis, the exact reasons why the disorder occurs in otherwise healthy persons remain unknown.

Although various factors are suspected to trigger the occurrence of multiple sclerosis (viral or bacterial infections) or to facilitate its progression (genetic dysfunctions and various external, environmental factors), medical scientists haven't yet reached a consensus regarding the exact causes of the disorder.

At first, multiple sclerosis causes impairments only at the level of the central nervous system. In more advanced stages of progression, multiple sclerosis can involve virtually any innervated region of the body (any part of the body that contains a network of nerves). Without proper medical treatment - which is most effective when administered in early stages of disease - multiple sclerosis can cause a variety of disabilities and sometimes even death.

Depending on its patterns of progression, as well as the intensity and frequency of its generated symptoms, multiple sclerosis can be categorized in seven different subtypes:

The first subtype of multiple sclerosis is the relapsing-remitting multiple sclerosis (RR MS), the most common form of the autoimmune disorder. According to statistics, more than 80 percent of all multiple sclerosis cases are of the relapsing-remitting subtype. This subtype is characterized by phases of symptomatic remission, followed by phases of relapse (characterized by sudden intensification of symptoms). The duration of the phases of relapse and remission vary from a patient to another, lasting anywhere from several weeks to several years.

The second subtype of multiple sclerosis - primary-progressive multiple sclerosis (PP MS) accounts for around 20 percent of all multiple sclerosis cases. The major characteristics of this subtype are gradual progression of the disease, with very short phases of remission.

The third multiple sclerosis subtype is similar to the PP MS subtype and is called secondary-progressive multiple sclerosis (SP MS). Patients with primary-progressive multiple sclerosis have 50 percent chances to eventually develop secondary-progressive multiple sclerosis.

The fourth subtype of multiple sclerosis is called progressive-relapsing multiple sclerosis (PR MS) and is characterized by gradual progression with frequent phases of symptomatic exacerbation.

The fifth multiple sclerosis subtype alternates between the primary-progressive, secondary-progressive and progressive-relapsing forms of the disease.

The sixth multiple sclerosis subtype is benign multiple sclerosis, characterized by an initial symptomatic flare which can be followed by slow or no progression at all.

The seventh and last multiple sclerosis subtype is also very rare. It is called malignant multiple sclerosis and involves rapid progression and very intense symptoms. This subtype is in most cases deadly.

Although there is no known cure for multiple sclerosis, several therapies have proven helpful. The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability.

Articles

Pub. DateTopicAuthor
2011-10-06Major Breakthrough in Multiple Sclerosis Found Using Upright MRIFONAR Corporation
2011-06-30Breakthrough in Search for Multiple Sclerosis TreatmentUniversity of Nottingham
2011-06-23Minimally Invasive Treatment for MS PatientsSociety of Interventional Radiology
2011-06-12Shingles May be Related to Elevated Risk of Multiple SclerosisInfectious Diseases Society of America
2011-05-19Viagra May Reduce MS SymptomsUniversitat Autonoma de Barcelona
2011-04-18Compound Effectively Halts Progression of Multiple SclerosisScripps Research Institute
2011-04-15Disability Timeline for Progressive MSMayo Clinic
2011-04-11Novartis Therapy GilenyaTM Reduced Risk of MS Disability ProgressionNovartis
2011-03-31Treatment of MS - Damage to Nerve Cells Can be ReversedLudwig-Maximilians-Universität München
2011-03-30Monitoring System for Multiple Sclerosis - CanadaGovernment of Canada
2011-03-14MS - How Do You Put a Face on a Disease that Affects Each Person DifferentlyNational Multiple Sclerosis Society
2011-03-10Multiple Sclerosis Oral Treatment Approved in CanadaNovartis Pharmaceuticals Canada Inc.
2011-03-07Fumaric Acid Salts for Psoriasis May Help Multiple SclerosisRuhr-University Bochum
2011-02-13Reduced Levels of Neurotransmitter in MSUniversity of Illinois at Chicago
2011-01-31Histamine May be Possible Drug Target for Multiple SclerosisFederation of American Societies for Experimental Biology
2010-12-20Significant Progress in Multiple Sclerosis Research in 2010National Multiple Sclerosis Society
2010-12-05New Possibility of Reversing Damage Caused by MSUniversity of Cambridge
2010-10-28Multiple Sclerosis Will Become a Controlled DiseaseIDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer
2010-10-17Ocrelizumab Shows Significant Reduction in Multiple Sclerosis Disease ActivityMultiple Sclerosis News
2010-09-13Asthma Medication May Benefit Patients with Multiple SclerosisJAMA and Archives Journals
2010-09-01CIHR Makes Recommendations on Canadian MS Research PrioritiesCanadian Institutes of Health Research
2010-08-28Bone Marrow Stem Cells in MS Show PromiseThe Multiple Sclerosis and Stem Cell Research Group
2010-08-26SIR Supports Research for New MS TreatmentsSociety of Interventional Radiology
2010-06-03Encouraging Results for Multiple Sclerosis TreatmentHard to Treat Diseases
2010-03-08Join the Movement to End Multiple SclerosisNational Multiple Sclerosis Society
2010-01-24Ampyra Approved by FDA for Adults with Multiple SclerosisU.S. Food and Drug Administration
2010-01-20New Drug Cladribine for Multiple Sclerosis Shows PromiseQueen Mary, University of London
2009-12-23National MS Society Continues to Propel Research Forward to End MSNational Multiple Sclerosis Society
2009-11-05Multiple Sclerosis Relapses and Severe DisabilityAmerican Academy of Neurology
2009-10-25Possible New Underlying Cause of Multiple SclerosisUniversity at Buffalo
2009-09-11Genes Identified as Potential Therapeutic Targets for Multiple SclerosisMayo Clinic
2009-09-10Brain Disease Virus Found in Natalizumab Treated MS PatientsBeth Israel Deaconess Medical Center
2009-08-11Researchers Successfully Reverse Multiple SclerosisMcGill University
2009-02-27Antegren Drug for Relapsing MSDisabled World
2009-02-27Naltrexone Treats Multiple Sclerosis - But Sufferers Can't Get itCris Kerr
2009-02-27Drug Improves Mobility For Some Multiple Sclerosis PatientsScienceDaily

Permalink




Email page
Email
Printable page
Print




In This Section

Health and Disability
Autoimmune Diseases


Top of Page

Reference Desk - Contact, About, Terms and Privacy Information, News Submissions

Information contained within is intended for your general information only and is not a substitute for medical advice or treatment.
Disabled World is not responsible for the content of external Internet sites. Disabled World(TM) www.disabled-world.com All rights reserved. 13201